Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China

NCT01459081 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

298

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza A Virus Infection
Influenza B Virus Infection

Interventions

DRUG: Zanamivir
DRUG: Placebo

Sponsor

Jiangsu Simcere Pharmaceutical Co., Ltd.